Trump’s health pick faces another round of criticism at hearing
By
Anna Edney
Published Updated
4 Min Read
More From Employee Benefit News
Trump’s immigration crackdown fails to deliver jobs for US-born workers
Despite job openings and increasing unemployment, employers are having a hard time filling roles formerly occupied by non-American workers.
Congress’ push to rein in drug costs will impact benefit strategies
New drug pricing proposals could reshape employer pharmacy strategy, as benefit managers struggle to navigate rising prescription costs.
JPMorgan, Bank of America are matching workers’ Trump account contributions
Chime Financial and BlackRock are among the other companies that have also promised to match the government's contribution.
Is employer health insurance at risk? A veteran benefits lobbyist weighs in
As Washington revisits the tax-favored status of health benefits, a longtime policy expert explains why replacing group plans could cost far more.
Mark Cuban lauds cash-pay option as Rx cost remedy
Cost Plus Drugs co-founder berates benefit advisers for not emphasizing cash carveouts as he seeks to better educate CEOs on how to avoid being ripped off.
